Linda Zukauckas
Director at TRU
Board
About Linda K. Zukauckas
Linda K. Zukauckas (age 63) is an independent director of TransUnion, serving since January 2023. She brings deep finance and accounting expertise as a former public company CFO and has been designated an “audit committee financial expert” by the Board. She holds a bachelor’s degree in business administration from Texas Tech University. Effective April 1, 2025, she became Chair of TransUnion’s Audit Committee.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Nielsen Holdings | Chief Financial Officer | Feb 2020 – Feb 2023 | Departed in connection with take-private; senior finance leadership at a large data/insights company |
| American Express | EVP/Deputy CFO; EVP/Controller & Chief Accounting Officer | 2011 – 2020 (Deputy CFO 2018–2020) | Led controllership and accounting; enterprise finance leadership |
| Ally Financial | Strategy/M&A; Divisional CFO; Head of Corporate Planning; Global Controller/Chief Accounting Officer; Global Head of Internal Audit | 2000 – 2011 | Broad finance, M&A and audit oversight across a global financial services firm |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Integrity, LLC (private, insurance distribution/wealth solutions) | Chief Financial Officer | Since Jul 2024 | Current operating role |
| Zelis (private healthtech) | Director | Current | Privately-held; modernizing healthcare financial experience |
| MTS Systems (public, NYSE; acquired) | Director | 2019 – 2021 | Prior public company board experience |
Board Governance
- Committee assignments and chair roles: Audit Committee member; appointed Audit Committee Chair effective Apr 1, 2025. Board identifies her as an “audit committee financial expert.”
- Independence: Board determined she is independent under NYSE rules.
- Attendance/engagement: Each director attended at least 75% of Board and committee meetings in 2024; Board met 5 times and all then-serving directors attended the 2024 Annual Meeting.
- Board leadership: Board chaired by Non-Executive Chair (Pamela Joseph); no Lead Director currently since CEO and Chair roles are separated, and non-management directors meet in executive session.
- Related person transaction oversight: Audit Committee reviews/approves any related person transactions per written policy.
Fixed Compensation
| Component (2024) | Amount (USD) | Notes |
|---|---|---|
| Annual Board Retainer | $95,000 | Standard non-employee director retainer |
| Committee Member Fees | $10,000 | Standard per-committee member fee; Linda earned $105,000 cash total in 2024 (retainer + member fee) |
| Audit Committee Chair Fee (rate) | $30,000 | Applicable to Audit Chair role; effective for chair service beginning Apr 1, 2025 |
- 2024 total cash fees earned: $105,000.
Performance Compensation
Directors receive time-vested restricted stock (no performance-conditioned metrics).
| Grant | Grant Date | Shares Granted | Grant-Date Fair Value (USD) | Vesting |
|---|---|---|---|---|
| Annual RS | May 2, 2024 | 2,543 | $189,937 | One-year cliff vest from grant date |
| Annual RS | May 7, 2025 | 2,463 | n/a | One-year cliff vest from grant date (Form 4 award) |
| RS (initial/annual) | Jan 30, 2023 | 2,442 | n/a | As reported on Form 4 |
| Annual RS | May 4, 2023 | 2,989 | n/a | As reported on Form 4 |
Performance metrics tied to director compensation: None disclosed; director equity is time-based RS with standard dividend equivalent accruals payable upon vesting.
Other Directorships & Interlocks
| Company | Current Public Board? | Committee Roles | Notes |
|---|---|---|---|
| — | None disclosed | — | Prior public: MTS Systems (2019–2021) |
- Compensation Committee interlocks: Company disclosed none among 2024 members (Fradin, Bosworth, Kumar, Joseph).
Expertise & Qualifications
- Audit/finance: Designated audit committee financial expert; former CFO, CAO and Controller roles across large public companies.
- Corporate governance and risk: Senior finance leadership with internal audit oversight; Board service at public/private companies.
- Industry: Financial services, payments/data, healthtech (private board), and information/insights (Nielsen).
Equity Ownership
| Measure | Data |
|---|---|
| Beneficial ownership (as of Mar 10, 2025) | 10,324 shares; less than 1% of outstanding |
| Shares outstanding (record date) | 195,140,439 |
| Ownership % of outstanding | ~0.0053% (calc. from 10,324 / 195,140,439) |
| Stock ownership guidelines | 5x annual retainer; retain 75% of after-tax shares until met |
| Compliance status (12/31/2024) | All applicable directors met guidelines, except Dia, Gottdiener, Kumar (Linda not excepted) |
| Hedging/pledging | Company policy prohibits pledging and hedging by officers, directors and employees |
Insider transactions (alignment signals)
| Transaction Date | Type | Shares | Price | Post-Transaction Ownership | Source |
|---|---|---|---|---|---|
| Oct 30, 2023 | Open-market purchase | 1,500 | $44.09 | 6,931 | |
| Oct 30, 2023 | Open-market purchase | 850 | $42.7906 | 7,781 | |
| Jan 30, 2023 | Award (RS) | 2,442 | $0 | 2,442 | |
| May 4, 2023 | Award (RS) | 2,989 | $0 | 5,431 | |
| May 2, 2024 | Award (RS) | 2,543 | $0 | 10,324 | |
| May 7, 2025 | Award (RS) | 2,463 | $0 | 12,787 |
Governance Assessment
- Board effectiveness: Elevation to Audit Committee Chair and designation as an audit committee financial expert strengthen oversight of financial reporting, controls and compliance; independence affirmed under NYSE rules.
- Attendance and engagement: Met at least 75% attendance threshold; full Board attendance at the 2024 Annual Meeting indicates engagement.
- Compensation and alignment: 2024 director pay mix skewed to equity (cash $105,000; equity grant value $189,937), supporting alignment; stock ownership guideline compliance and insider purchases in 2023 further reinforce skin-in-the-game.
- Conflicts/related-party exposure: No related person transactions disclosed; robust policy requires Audit Committee review of any such transactions. Anti-hedging/pledging policy mitigates alignment risks.
- Shareholder signals: Company’s most recent Say-on-Pay support at 95.78% indicates broad investor support for compensation governance (company-level signal).
RED FLAGS
- None disclosed regarding attendance shortfalls, related-party transactions, hedging/pledging, or compensation anomalies for directors. Audit chair transition appears orderly with clear expertise designation.